G GINKGO BIOWORKS HOLDINGS INC
| Market Cap | $427.28M |
| P/E Ratio | — |
| Forward P/E | -1.90 |
| Dividend Yield | — |
| Beta | 1.57 |
| 52W Range | $5.48 - $16.14 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 0.08% | $29.73M | 3,577,128 | — |
Insider Trading
| Insider Name of the company insider who made the trade 5 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Coen Steven P.See remarks | Sale | 708 | $6.74 | $4.77K | 16 Mar 2026 | 13 Mar 2026 |
| Coen Steven P.See remarks | Sale | 972 | $8.92 | $8.67K | 20 Jan 2026 | 22 Jan 2026 |
| Coen Steven P.See remarks | Sale | 736 | $8.89 | $6.54K | 15 Dec 2025 | 16 Dec 2025 |
| Coen Steven P.See remarks | Sale | 1,312 | $13.65 | $17.91K | 17 Oct 2025 | 21 Oct 2025 |
| Steven P. CoenChief Financial Officer | Sale | 1,312 | $13.65 | $17.91K | 17 Oct 2025 | 21 Oct 2025 |
Frequently Asked Questions
What is DNA stock price today?
GINKGO BIOWORKS HOLDINGS INC (DNA) is currently trading at $6.90. The stock has a 52-week range of $5.48 to $16.14 and a market capitalization of $427.28M.
Is DNA a good stock to buy in 2026?
GINKGO BIOWORKS HOLDINGS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +21.1%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling DNA stock?
There have been 5 insider transactions for DNA in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has DNA stock performed over the past year?
GINKGO BIOWORKS HOLDINGS INC (DNA) has returned +21.1% over the past 12 months. The stock traded between $5.48 and $16.14 during this period, and is currently at $6.90.
Which hedge funds own DNA (GINKGO BIOWORKS HOLDINGS INC)?
1 tracked hedge funds currently hold DNA in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is DNA's market cap and valuation?
GINKGO BIOWORKS HOLDINGS INC (DNA) has a market capitalization of $427.28M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is DNA's revenue and profitability?
GINKGO BIOWORKS HOLDINGS INC reported revenue of $170.16M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.57.
What sector is DNA in and who are its biggest institutional holders?
GINKGO BIOWORKS HOLDINGS INC (DNA) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.